Nandita S. Scott

ORCID: 0000-0003-3261-7833
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Issues in Pregnancy
  • Cardiac Structural Anomalies and Repair
  • Pregnancy and preeclampsia studies
  • Birth, Development, and Health
  • Cardiac Health and Mental Health
  • Congenital Heart Disease Studies
  • Cardiac Arrhythmias and Treatments
  • Cardiovascular Function and Risk Factors
  • Maternal and fetal healthcare
  • Pulmonary Hypertension Research and Treatments
  • Cardiac Imaging and Diagnostics
  • Sex and Gender in Healthcare
  • Cardiovascular Health and Risk Factors
  • Heart Failure Treatment and Management
  • Cardiomyopathy and Myosin Studies
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Hormonal Regulation and Hypertension
  • Aortic Disease and Treatment Approaches
  • Acute Myocardial Infarction Research
  • Estrogen and related hormone effects
  • Hemodynamic Monitoring and Therapy
  • Cardiovascular and Diving-Related Complications
  • Corporate Taxation and Avoidance
  • Cardiac Valve Diseases and Treatments
  • Menopause: Health Impacts and Treatments

Massachusetts General Hospital
2016-2025

Harvard University
2002-2024

University of Bergen
2020

Boston University
2017-2018

Lemuel Shattuck Hospital
2018

Center for Systems Biology
2017

Ludwig-Maximilians-Universität München
2017

Broad Institute
2017

German Centre for Cardiovascular Research
2017

LMU Klinikum
2017

Recent guidelines endorse using history of menopause before age 40 years to refine atherosclerotic cardiovascular disease risk assessments among middle-aged women. Robust data on in this population are lacking.To examine the development diseases and factors women with natural surgical years.Cohort study (UK Biobank), adult residents United Kingdom recruited between 2006 2010. Of who were 69 old postmenopausal at enrollment, 144 260 eligible for inclusion. Follow-up occurred through August...

10.1001/jama.2019.19191 article EN JAMA 2019-11-18

Background— Percutaneous transcatheter closure of patent foramen ovale (PFO) is used as an alternative to surgery or long-term anticoagulation for the treatment patients with paradoxical embolism and PFO. Methods Results— We report immediate clinical echocardiographic outcome 110 consecutive (58 males, mean age 47±14 years) who underwent PFO because between 1995 2001. Procedural success, defined successful deployment device effective occlusion (no, trivial, shunt after placement), was...

10.1161/01.cir.0000027819.19722.ee article EN Circulation 2002-08-27

BACKGROUND: Preeclampsia is a pregnancy-specific hypertensive disorder associated with an imbalance in circulating proangiogenic and antiangiogenic proteins. Preclinical evidence implicates microvascular dysfunction as potential mediator of preeclampsia-associated cardiovascular risk. METHODS: Women singleton pregnancies complicated by severe antepartum-onset preeclampsia comparator group normotensive deliveries underwent cardiac positron emission tomography within 4 weeks delivery. A...

10.1161/hypertensionaha.124.22905 article EN Hypertension 2024-04-02

Restrictive cardiomyopathy (RCM) is a rare characterized by impaired diastolic ventricular function resulting in poor clinical prognosis. Rarely, heritable forms of RCM have been reported, and mutations underlying identified genes that govern the contractile cardiomyocytes.We evaluated 8 family members across 4 generations history, physical examination, electrocardiography, echocardiography. Affected individuals presented with pleitropic syndrome progressive RCM, atrioventricular septal...

10.1161/circgenetics.117.001780 article EN Circulation Cardiovascular Genetics 2017-12-01

Hypertensive disorders of pregnancy (HDP) have been associated with heart failure (HF). It is unknown whether concurrent complications (small-for-gestational-age or preterm delivery) recurrent HDP modify HDP-associated HF risk. In this cohort study, we included Norwegian women a first birth between 1980 and 2004. Follow-up occurred through 2009. Cox models examined gestational hypertension preeclampsia in the as predictors composite HF-related hospitalization death, assessment effect...

10.1161/hypertensionaha.120.15654 article EN Hypertension 2020-08-24

Background Cardiovascular disease is the leading cause of death during pregnancy with thoracic aortic dissection being one main causes. Thoracic commonly related to hereditary disorders and congenital heart malformations such as bicuspid valve (BAV). Pregnancy considered a high risk period in women underlying aortopathy. Methods The ESC EORP Registry Of And Cardiac (ROPAC) prospective global registry that enrolled 5739 pre-existing cardiac disease. With this analysis, we aim study maternal...

10.1136/heartjnl-2020-318183 article EN cc-by-nc Heart 2021-01-19

Cardiac biomarkers are widely used in the nonpregnant population when acute cardiovascular (CV) pathology is suspected; however, behavior of these context pregnancy less well understood. Pregnant individuals often have symptoms that mimic those cardiac dysfunction, and complications may include CV disease. This paper will summarize our current knowledge on use provide suggestions how to tools clinical practice based available evidence. Natriuretic peptides troponin should not be measured...

10.1016/j.jacadv.2022.100064 article EN cc-by JACC Advances 2022-08-01

Maternal Cardiovascular Health Post-DobbsPregnancy is associated with increasing morbidity and mortality in the United States. In post-Dobbs era, many pregnant patients at highest risk no longer have access to abortion, which has been a crucial component of standard medical care.

10.1056/evidra2300273 article EN NEJM Evidence 2024-01-23
Coming Soon ...